RESUMO
Objective: To evaluate the incidence of contrast-induced nephropathy [CIN] and its contributing factors after cardiac catheterization in type II diabetic patients. Study Design: Cross sectional study. Place and Duration of Study: Choudhary Pervaiz Ellahi Institute of Cardiology [CPEIC], Multan for six months, from Aug 2016 to Mar 2017
Material and Methods: This cross sectional study was conducted and completed in the department of cardiology Choudhary Pervaiz Ellahi Institute of Cardiology [CPEIC], Multan for six months [August 2016 to March 2017]. Before start of the study ethical approval was obtained from hospital ethical board/committee; informed consent was taken from patients and their attendants after complete information and they were also ensured about their confidentiality. All collected data was aligned and entered in a computer software SPSS version 23.1 and data was analyzed. Mean +/- SD values were calculated and presented for quantitative data variables like age, similarly frequency [percentages] were calculated and presented for qualitative variable data like gender. After stratification of data, student chi square test was used to see effect modification. A p-value
Results: A total number of 255 patients were included in the study. All patients were admitted for cardiac catheterization. Participants of the study were divided into two groups on the basis of CIN presence. Group A consisted of 210 patients who didn't develop contrast-induced nephropathy [CIN] after catheterization of coronary artery. Group B consisted of 45 patients of CIN after catheterization of coronary artery. It was found that incidence of CIN in diabetic patients with micro-albuminuria was 17.64% [n=45]
Conclusion: Observation of our study found that diabetic patients either with normal baseline creatinine are at an increased risk of developing CIN after angiography of coronary artery
RESUMO
Long term vascular access has become more important as patients live longer on dialysis. Improved survival on hemodialysis has resulted in an increasing number of patients with failed vascular access, so an increasing number of options for vascular access have to be added to the surgeon's armamentarium. In a number of patients, basilic vein transposition is an often overlooked means of arteriovenous access that has a superior patency compared with bridge fistulas using polytetrafluoroethylene [PTFE]. And this brought vascular surgeons of Imam-Reza hospital to use this technique in patients with complications in normal fistulas. This article evaluates the survival rate of these fistulas and compares them with patency rates reported worldwide. This study was conducted on, 25 End Stage Renal Disease [ESRD] patients, undergone superficial basilic vein transposition from 2002 till 2005. In these patients, superficial basilic vein transposition method was performed for an arteriovenous fistula [AVF]. Demographic data were collected using medical records, and then patients were examined clinically. Patency rate was evaluated using life tables by SPSS version 13 and compared with similar results reported worldwide. Overall 70.8% were male patients and 29.2% were female. Hypertension was seen in 87.5% of cases and 37.5% suffered from diabetes. Seventy four percent of our cases underwent basilic vein transposition after a failing AVF, one case after a rejected transplant and one after a failed graft. The longest patency rate was 30 months and the shortest was 4 months. The patency rate for the first 6 months was 86% and after one year 77% and after 26 months 58%. The one year patency rate reported for fistulas by basilica vein transposition method is 90-60% which justifies the results of this article [62.5%]. these results suggest that this method can be used as a new access line for dialyzing ESRD patients before using graft fistulas